CNS/Neurology Research Reports
Brain Hemorrhage Global Clinical Trials Review, H1, 2012
Topics: Clinical Trial, CNS/Neurology
Regions: Global
| Brain Injury Global Clinical Trials Review, H1, 2012
Topics: Clinical Trial, CNS/Neurology
Regions: Global
| Cerebral Infarction (Brain Infarction) Global Clinical Trials Review, H1, 2012
Topics: Clinical Trial, CNS/Neurology
Regions: Global
| Cluster Headache Syndrome Global Clinical Trials Review, H1, 2012
Topics: Clinical Trial, CNS/Neurology
Regions: Global
| Tension -Type Headache Global Clinical Trials Review, H1, 2012
Topics: Pain, Clinical Trial, CNS/Neurology
Regions: Global
| Traumatic Brain Injury Global Clinical Trials Review, H1, 2012
Topics: Clinical Trial, CNS/Neurology
Regions: Global
| Amyotrophic Lateral Sclerosis Global Clinical Trials Review, H1, 2012
Topics: Clinical Trial, CNS/Neurology
Regions: Global
| Brain Ischemia Global Clinical Trials Review, H1, 2012
Topics: Clinical Trial, CNS/Neurology
Regions: Global
| Orphan Diseases Therapeutics in CNS to 2017 - Novel Agents such as AMR101 and ACR16 to Provide Treatment Options and Boost the Huntington’s Disease Segment
Topics: Huntington's, Manufacturing, Packaging & Detailing, Regulation & Policy, Research & Development, Diseases & Conditions, CNS/Neurology
| Mild Cognitive Impairment Global Clinical Trials Review, H1, 2012
Topics: Drug Discovery, Clinical Trial, CNS/Neurology
Regions: Global
| Opium (Opioid) Addiction – Pipeline Review, H1 2012
Topics: Drug Discovery, CNS/Neurology
| Brain Hemorrhage – Pipeline Review, H1 2012
Topics: Drug Discovery, CNS/Neurology
| Psychosis – Pipeline Review, H1 2012
Topics: Drug Discovery, CNS/Neurology
| Narcolepsy Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Topics: Drug Discovery, CNS/Neurology
| Tourette Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Topics: Drug Discovery, CNS/Neurology
| Childhood Epilepsy Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Topics: Drug Discovery, CNS/Neurology
| Panic Disorder Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Topics: Drug Discovery, CNS/Neurology
| Schizophrenia – Pipeline Review, H1 2012
Topics: Drug Discovery, CNS/Neurology
| Epilepsy – Pipeline Review, H1 2012
Topics: Drug Discovery, CNS/Neurology
| Major Depressive Disorder – Pipeline Review, H1 2012
Topics: Drug Discovery, CNS/Neurology
| Migraine – Pipeline Review, H1 2012
Topics: Drug Discovery, CNS/Neurology
| Autism – Pipeline Review, H1 2012
Topics: Drug Discovery, CNS/Neurology
| Bipolar Disorder (Manic Depression) – Pipeline Review, H1 2012
Topics: Drug Discovery, CNS/Neurology, Behavioral Health
| Amyotrophic Lateral Sclerosis – Pipeline Review, H1 2012
Topics: Drug Discovery, CNS/Neurology
| Attention Deficit Hyperactivity Disorder (ADHD) – Pipeline Review, H1 2012
Topics: Drug Discovery, CNS/Neurology
| Brain Cancer Drug Pipeline Update 2012
Topics: Drug Discovery, CNS/Neurology, Oncology/Hematology
| Alcohol Addiction Global Clinical Trials Review, H1, 2012
Topics: Drug Discovery, Clinical Trial, CNS/Neurology
| The CNS Pipeline Fact Book 2012
Topics: CNS/Neurology
| Social Anxiety Disorders (SAD) Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Topics: Drug Discovery, CNS/Neurology
| Psychotic Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Topics: Drug Discovery, CNS/Neurology
| Anaplastic Astrocytoma Global Clinical Trials Review, H1, 2012
Topics: Drug Discovery, Clinical Trial, CNS/Neurology
| Metastatic Brain Tumor Global Clinical Trials Review, H1, 2012
Topics: Drug Discovery, Clinical Trial, CNS/Neurology
| Depression Global Clinical Trials Review, H1, 2012
Topics: Drug Discovery, CNS/Neurology
| Tinnitus Global Clinical Trials Review, H1, 2012
Topics: Drug Discovery, Clinical Trial, CNS/Neurology
| Glioblastoma Multiforme (GBM) – Pipeline Review, H1 2012
Topics: Drug Discovery, CNS/Neurology
| CNS Lymphoma – Pipeline Review, H1 2012
Topics: Drug Discovery, CNS/Neurology, Oncology/Hematology
| Neuroblastoma - Pipeline Review, H1 2012
Topics: Drug Discovery, CNS/Neurology
| Glioma - Pipeline Review, H1 2012
Topics: Drug Discovery, CNS/Neurology
| Mental Retardation Facilities in the US - Industry Risk Rating Report
Topics: Facilities, CNS/Neurology
Regions: United States
| Attention Deficit Hyperactivity Disorder (ADHD) Global Clinical Trials Review, H1, 2012
Topics: Drug Discovery, Clinical Trial, CNS/Neurology
| Antipsychotics Market to 2017 - Patent Expiries for Zyprexa, Abilify, Seroquel and Geodon and the Launch of Generic Versions Will Limit Commercial Opportunities for Pipeline Molecules
Topics: CNS/Neurology
| Addiction Control Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Topics: Drug Discovery, CNS/Neurology
| Generalized Anxiety Disorders (GAD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Topics: Drug Discovery, CNS/Neurology
| Glioma Global Clinical Trials Review, H2, 2011
Topics: Clinical Trial, CNS/Neurology
| Narcolepsy - Pipeline Review, H2 2011
Topics: Drug Discovery, CNS/Neurology
| Addiction - Pipeline Review, H2 2011
Topics: Drug Discovery, CNS/Neurology
| Epilepsy Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Topics: Drug Discovery, CNS/Neurology
| Opium Addiction Global Clinical Trials Review, H2, 2011
Topics: Drug Discovery, CNS/Neurology
| There Is an Urgent Need for More Efficacious High-Grade Glioma Treatments, but Will the Current Therapeutic Pipeline Suffice?
Topics: Drug Discovery, CNS/Neurology
| Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Topics: Drug Discovery, CNS/Neurology
|
Prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Next
About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports, company profiles and country profiles from over 720 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.
|
